m6A-related lncRNAs are potential biomarkers for predicting prognoses and immune responses in patients with LUAD
Lung adenocarcinoma (LUAD) is the most frequent subtype of lung cancer worldwide. However, the survival rate of LUAD patients remains low. N6-methyladenosine (m6A) and long noncoding RNAs (lncRNAs) play vital roles in the prognostic value and the immunotherapeutic response of LUAD. Thus, discerning...
Main Authors: | Feng Xu, Xiaoling Huang, Yangyi Li, Yongsong Chen, Ling Lin |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-06-01
|
Series: | Molecular Therapy: Nucleic Acids |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2162253121000974 |
Similar Items
-
N6-methyladenosine-related lncRNAs identified as potential biomarkers for predicting the overall survival of Asian gastric cancer patients
by: Shuyu Xu, et al.
Published: (2022-07-01) -
The role of lncRNAs and exosomal lncRNAs in cancer metastasis
by: Yutong Zhang, et al.
Published: (2023-09-01) -
Cuproptosis- and m6A-Related lncRNAs for Prognosis of Hepatocellular Carcinoma
by: Yuezhi Zhu, et al.
Published: (2023-08-01) -
Integrative Analysis Reveals Potentially Functional N6-Methylandenosine-Related Long Noncoding RNAs in Colon Adenocarcinoma
by: Xinjie Tan, et al.
Published: (2021-09-01) -
N6-Methyladenosine-Related LncRNAs Are Potential Remodeling Indicators in the Tumor Microenvironment and Prognostic Markers in Osteosarcoma
by: Zhongguang Wu, et al.
Published: (2022-01-01)